Towards Healthcare
Precision Oncology Market Size Boosts 9.9% CAGR by 2034

Precision Oncology Market Size, Business Strategies & Trends (2024 - 34)

The precision oncology market size is calculated at $132.87 bn in 2025 is to hit $310.75 bn by 2034. COTA, Inc. and Guardant Health collaborated to advance biomarker-based cancer therapies. Caris Life Sciences added UVA Cancer Center to its Precision Oncology Alliance. Scorpion Therapeutics raised $150M for STX-478. NIH launched myeloMATCH trials, and LabCorp expanded precision oncology with Plasma Detect.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Precision Oncology Market Assessment

  • Overview
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa

North America Precision Oncology Market Assessment

  • Overview
  • North America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • North America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • North America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Europe Precision Oncology Market Assessment

  • Overview
  • Europe Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Europe Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Europe Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Asia-Pacific Precision Oncology Market Assessment

  • Overview
  • Asia-Pacific Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Asia-Pacific Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Asia-Pacific Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Latin America Precision Oncology Market Assessment

  • Overview
  • Latin America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Latin America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Latin America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Middle East and Africa Precision Oncology Market Assessment

  • Overview
  • Middle East and Africa Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Middle East and Africa Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Middle East and Africa Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Company Profiles

  • Thermo Fisher Scientific, Inc. 
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Invitae Corporation
  • Illumina, Inc.
  • Myriad Genetics, Inc
  • AstraZeneca
  • Rain Oncology Inc.
  • Strata Oncology, Inc.
  • Repare Therapeutics
  • Relay Therapeutics
  • Exscientia
  • Exact Sciences Corporation

Conclusion & Recommendations

  • Insight Code: 5054
  • No. of Pages: 150
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The field of precision oncology is rapidly advancing, with ongoing research and clinical trials focused on identifying new genetic alterations and developing targeted therapies. As our understanding of cancer genetics continues to grow, precision oncology is expected to play a significant role in shaping the future of cancer treatment.

Some challenges of precision oncology include the high cost of genetic testing, the need for comprehensive tumor profiling, limited availability of targeted therapies for certain genetic alterations, and the complexity of interpreting genomic data and translating it into effective treatment strategies.

Precision oncology offers the potential for personalized treatment options that are tailored to the genetic makeup of a patients tumor. This can lead to improved treatment outcomes, reduced side effects, and better overall patient care.

American Cancer Society Inc, National Library of Medicine, and World Health Organization